nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2B6—Thiotepa—hematologic cancer	0.0373	0.05	CbGbCtD
Carbinoxamine—CYP2E1—Thalidomide—hematologic cancer	0.0244	0.0327	CbGbCtD
Carbinoxamine—CYP2C9—Bexarotene—hematologic cancer	0.0238	0.0319	CbGbCtD
Carbinoxamine—CYP2B6—Ifosfamide—hematologic cancer	0.0212	0.0284	CbGbCtD
Carbinoxamine—CYP2E1—Dacarbazine—hematologic cancer	0.021	0.0281	CbGbCtD
Carbinoxamine—CYP2C8—Bortezomib—hematologic cancer	0.0209	0.028	CbGbCtD
Carbinoxamine—CYP2D6—Lomustine—hematologic cancer	0.0202	0.0271	CbGbCtD
Carbinoxamine—CYP2C9—Idarubicin—hematologic cancer	0.0197	0.0264	CbGbCtD
Carbinoxamine—CYP2B6—Nilotinib—hematologic cancer	0.0184	0.0246	CbGbCtD
Carbinoxamine—CYP2D6—Idarubicin—hematologic cancer	0.018	0.0242	CbGbCtD
Carbinoxamine—CYP2C19—Bortezomib—hematologic cancer	0.0175	0.0235	CbGbCtD
Carbinoxamine—CYP2E1—Mitoxantrone—hematologic cancer	0.0163	0.0218	CbGbCtD
Carbinoxamine—CYP2C8—Ifosfamide—hematologic cancer	0.016	0.0215	CbGbCtD
Carbinoxamine—CYP2D6—Hydroxyurea—hematologic cancer	0.0153	0.0205	CbGbCtD
Carbinoxamine—CYP2C19—Thalidomide—hematologic cancer	0.0153	0.0205	CbGbCtD
Carbinoxamine—CYP2C9—Bortezomib—hematologic cancer	0.0146	0.0195	CbGbCtD
Carbinoxamine—CYP2C19—Teniposide—hematologic cancer	0.0146	0.0195	CbGbCtD
Carbinoxamine—CYP2C8—Nilotinib—hematologic cancer	0.0139	0.0187	CbGbCtD
Carbinoxamine—CYP3A4—Bexarotene—hematologic cancer	0.0138	0.0185	CbGbCtD
Carbinoxamine—CYP2C19—Ifosfamide—hematologic cancer	0.0135	0.018	CbGbCtD
Carbinoxamine—CYP2D6—Bortezomib—hematologic cancer	0.0133	0.0179	CbGbCtD
Carbinoxamine—CYP3A4—Busulfan—hematologic cancer	0.0129	0.0172	CbGbCtD
Carbinoxamine—CYP3A4—Lomustine—hematologic cancer	0.0129	0.0172	CbGbCtD
Carbinoxamine—CYP2C19—Imatinib—hematologic cancer	0.0129	0.0172	CbGbCtD
Carbinoxamine—CYP2C9—Thalidomide—hematologic cancer	0.0127	0.017	CbGbCtD
Carbinoxamine—CYP2B6—Irinotecan—hematologic cancer	0.0126	0.0169	CbGbCtD
Carbinoxamine—CYP2C9—Teniposide—hematologic cancer	0.0121	0.0162	CbGbCtD
Carbinoxamine—CYP3A4—Thiotepa—hematologic cancer	0.0115	0.0154	CbGbCtD
Carbinoxamine—CYP2C9—Ifosfamide—hematologic cancer	0.0112	0.015	CbGbCtD
Carbinoxamine—CYP2C9—Imatinib—hematologic cancer	0.0107	0.0143	CbGbCtD
Carbinoxamine—CYP2B6—Cisplatin—hematologic cancer	0.0103	0.0138	CbGbCtD
Carbinoxamine—CYP2E1—Etoposide—hematologic cancer	0.0103	0.0138	CbGbCtD
Carbinoxamine—CYP2D6—Imatinib—hematologic cancer	0.00977	0.0131	CbGbCtD
Carbinoxamine—CYP2C9—Nilotinib—hematologic cancer	0.00971	0.013	CbGbCtD
Carbinoxamine—CYP3A4—Methoxsalen—hematologic cancer	0.00892	0.012	CbGbCtD
Carbinoxamine—CYP2D6—Nilotinib—hematologic cancer	0.00888	0.0119	CbGbCtD
Carbinoxamine—CYP2D6—Vinorelbine—hematologic cancer	0.00881	0.0118	CbGbCtD
Carbinoxamine—CYP3A4—Bortezomib—hematologic cancer	0.00848	0.0114	CbGbCtD
Carbinoxamine—CYP2C19—Prednisone—hematologic cancer	0.00847	0.0114	CbGbCtD
Carbinoxamine—CYP2E1—Dexamethasone—hematologic cancer	0.00843	0.0113	CbGbCtD
Carbinoxamine—CYP2B6—Dexamethasone—hematologic cancer	0.00832	0.0112	CbGbCtD
Carbinoxamine—CYP3A4—Daunorubicin—hematologic cancer	0.00811	0.0109	CbGbCtD
Carbinoxamine—CYP2C8—Etoposide—hematologic cancer	0.00767	0.0103	CbGbCtD
Carbinoxamine—CYP3A4—Cytarabine—hematologic cancer	0.00716	0.00959	CbGbCtD
Carbinoxamine—CYP3A4—Teniposide—hematologic cancer	0.00705	0.00945	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—hematologic cancer	0.0069	0.00925	CbGbCtD
Carbinoxamine—CYP3A4—Ifosfamide—hematologic cancer	0.0065	0.00872	CbGbCtD
Carbinoxamine—CYP2C8—Dexamethasone—hematologic cancer	0.0063	0.00845	CbGbCtD
Carbinoxamine—CYP3A4—Imatinib—hematologic cancer	0.00621	0.00833	CbGbCtD
Carbinoxamine—CYP3A4—Ruxolitinib—hematologic cancer	0.00585	0.00784	CbGbCtD
Carbinoxamine—CYP3A4—Nilotinib—hematologic cancer	0.00565	0.00757	CbGbCtD
Carbinoxamine—CYP3A4—Vinorelbine—hematologic cancer	0.0056	0.0075	CbGbCtD
Carbinoxamine—CYP2C9—Cisplatin—hematologic cancer	0.00544	0.00729	CbGbCtD
Carbinoxamine—CYP2D6—Vinblastine—hematologic cancer	0.00543	0.00727	CbGbCtD
Carbinoxamine—CYP2C19—Dexamethasone—hematologic cancer	0.00529	0.00709	CbGbCtD
Carbinoxamine—CYP3A4—Triamcinolone—hematologic cancer	0.00512	0.00686	CbGbCtD
Carbinoxamine—CYP3A4—Dasatinib—hematologic cancer	0.00499	0.00669	CbGbCtD
Carbinoxamine—CYP3A4—Mitoxantrone—hematologic cancer	0.00493	0.00661	CbGbCtD
Carbinoxamine—CYP2C9—Dexamethasone—hematologic cancer	0.0044	0.00589	CbGbCtD
Carbinoxamine—CYP3A4—Betamethasone—hematologic cancer	0.00439	0.00589	CbGbCtD
Carbinoxamine—CYP3A4—Prednisolone—hematologic cancer	0.00434	0.00581	CbGbCtD
Carbinoxamine—CYP3A4—Prednisone—hematologic cancer	0.00409	0.00549	CbGbCtD
Carbinoxamine—CYP2D6—Dexamethasone—hematologic cancer	0.00402	0.00539	CbGbCtD
Carbinoxamine—CYP3A4—Irinotecan—hematologic cancer	0.00388	0.0052	CbGbCtD
Carbinoxamine—CYP3A4—Vinblastine—hematologic cancer	0.00345	0.00462	CbGbCtD
Carbinoxamine—CYP3A4—Vincristine—hematologic cancer	0.00339	0.00455	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—hematologic cancer	0.00333	0.00447	CbGbCtD
Carbinoxamine—CYP3A4—Etoposide—hematologic cancer	0.00311	0.00417	CbGbCtD
Carbinoxamine—CYP3A4—Dexamethasone—hematologic cancer	0.00256	0.00343	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—hematologic cancer	0.00212	0.00284	CbGbCtD
Carbinoxamine—Chlorphenamine—SLC22A1—hematologic cancer	0.000172	0.251	CrCbGaD
Carbinoxamine—CYP2C19—hematopoietic system—hematologic cancer	0.00017	0.0719	CbGeAlD
Carbinoxamine—CYP2C8—hematopoietic system—hematologic cancer	0.000149	0.0627	CbGeAlD
Carbinoxamine—Clomipramine—GSTP1—hematologic cancer	0.000139	0.204	CrCbGaD
Carbinoxamine—CYP2B6—hematopoietic system—hematologic cancer	0.000133	0.0563	CbGeAlD
Carbinoxamine—CYP2C9—hematopoietic system—hematologic cancer	0.000132	0.0557	CbGeAlD
Carbinoxamine—HRH1—hematopoietic system—hematologic cancer	0.00013	0.055	CbGeAlD
Carbinoxamine—CYP2E1—hematopoietic system—hematologic cancer	0.000125	0.0528	CbGeAlD
Carbinoxamine—Diphenhydramine—SLC22A1—hematologic cancer	0.000116	0.171	CrCbGaD
Carbinoxamine—CYP2C19—blood—hematologic cancer	0.000113	0.0476	CbGeAlD
Carbinoxamine—Drowsiness—Methotrexate—hematologic cancer	0.000103	0.000454	CcSEcCtD
Carbinoxamine—Headache—Bortezomib—hematologic cancer	0.000103	0.000452	CcSEcCtD
Carbinoxamine—Hypotension—Etoposide—hematologic cancer	0.000103	0.000451	CcSEcCtD
Carbinoxamine—Asthenia—Carmustine—hematologic cancer	0.000102	0.000448	CcSEcCtD
Carbinoxamine—Vomiting—Vinorelbine—hematologic cancer	0.000102	0.000448	CcSEcCtD
Carbinoxamine—CYP2B6—gonad—hematologic cancer	0.000101	0.0428	CbGeAlD
Carbinoxamine—Diarrhoea—Thalidomide—hematologic cancer	0.000101	0.000445	CcSEcCtD
Carbinoxamine—Dizziness—Thiotepa—hematologic cancer	0.000101	0.000445	CcSEcCtD
Carbinoxamine—Asthenia—Alitretinoin—hematologic cancer	0.000101	0.000444	CcSEcCtD
Carbinoxamine—CYP3A4—hematopoietic system—hematologic cancer	0.000101	0.0425	CbGeAlD
Carbinoxamine—Headache—Vinorelbine—hematologic cancer	0.0001	0.000441	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—hematologic cancer	0.0001	0.00044	CcSEcCtD
Carbinoxamine—Asthenia—Ifosfamide—hematologic cancer	9.99e-05	0.000439	CcSEcCtD
Carbinoxamine—Vertigo—Betamethasone—hematologic cancer	9.97e-05	0.000438	CcSEcCtD
Carbinoxamine—Vertigo—Dexamethasone—hematologic cancer	9.97e-05	0.000438	CcSEcCtD
Carbinoxamine—CYP2D6—hematopoietic system—hematologic cancer	9.91e-05	0.0418	CbGeAlD
Carbinoxamine—Photosensitivity reaction—Epirubicin—hematologic cancer	9.9e-05	0.000435	CcSEcCtD
Carbinoxamine—Feeling abnormal—Cisplatin—hematologic cancer	9.9e-05	0.000435	CcSEcCtD
Carbinoxamine—Paraesthesia—Etoposide—hematologic cancer	9.88e-05	0.000434	CcSEcCtD
Carbinoxamine—CYP2C8—blood—hematologic cancer	9.85e-05	0.0416	CbGeAlD
Carbinoxamine—Insomnia—Prednisolone—hematologic cancer	9.81e-05	0.000431	CcSEcCtD
Carbinoxamine—Dizziness—Thalidomide—hematologic cancer	9.8e-05	0.00043	CcSEcCtD
Carbinoxamine—Somnolence—Etoposide—hematologic cancer	9.78e-05	0.000429	CcSEcCtD
Carbinoxamine—Nausea—Bortezomib—hematologic cancer	9.76e-05	0.000428	CcSEcCtD
Carbinoxamine—Asthenia—Vincristine—hematologic cancer	9.74e-05	0.000428	CcSEcCtD
Carbinoxamine—Paraesthesia—Prednisolone—hematologic cancer	9.74e-05	0.000428	CcSEcCtD
Carbinoxamine—Tachycardia—Triamcinolone—hematologic cancer	9.74e-05	0.000428	CcSEcCtD
Carbinoxamine—Vomiting—Thiotepa—hematologic cancer	9.74e-05	0.000428	CcSEcCtD
Carbinoxamine—Diarrhoea—Carmustine—hematologic cancer	9.73e-05	0.000427	CcSEcCtD
Carbinoxamine—Nausea—Bleomycin—hematologic cancer	9.68e-05	0.000425	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—hematologic cancer	9.67e-05	0.000425	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Triamcinolone—hematologic cancer	9.65e-05	0.000424	CcSEcCtD
Carbinoxamine—Diarrhoea—Alitretinoin—hematologic cancer	9.64e-05	0.000423	CcSEcCtD
Carbinoxamine—Agranulocytosis—Methotrexate—hematologic cancer	9.64e-05	0.000423	CcSEcCtD
Carbinoxamine—Convulsion—Betamethasone—hematologic cancer	9.61e-05	0.000422	CcSEcCtD
Carbinoxamine—Convulsion—Dexamethasone—hematologic cancer	9.61e-05	0.000422	CcSEcCtD
Carbinoxamine—Headache—Thiotepa—hematologic cancer	9.59e-05	0.000421	CcSEcCtD
Carbinoxamine—Decreased appetite—Etoposide—hematologic cancer	9.56e-05	0.00042	CcSEcCtD
Carbinoxamine—Diarrhoea—Ifosfamide—hematologic cancer	9.53e-05	0.000419	CcSEcCtD
Carbinoxamine—Nausea—Vinorelbine—hematologic cancer	9.53e-05	0.000418	CcSEcCtD
Carbinoxamine—Asthenia—Mitoxantrone—hematologic cancer	9.49e-05	0.000417	CcSEcCtD
Carbinoxamine—Asthenia—Irinotecan—hematologic cancer	9.49e-05	0.000417	CcSEcCtD
Carbinoxamine—Fatigue—Etoposide—hematologic cancer	9.48e-05	0.000417	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—hematologic cancer	9.48e-05	0.000416	CcSEcCtD
Carbinoxamine—Vomiting—Thalidomide—hematologic cancer	9.42e-05	0.000414	CcSEcCtD
Carbinoxamine—Dizziness—Carmustine—hematologic cancer	9.41e-05	0.000413	CcSEcCtD
Carbinoxamine—Constipation—Etoposide—hematologic cancer	9.41e-05	0.000413	CcSEcCtD
Carbinoxamine—Dizziness—Alitretinoin—hematologic cancer	9.32e-05	0.000409	CcSEcCtD
Carbinoxamine—Diarrhoea—Vincristine—hematologic cancer	9.29e-05	0.000408	CcSEcCtD
Carbinoxamine—Headache—Thalidomide—hematologic cancer	9.28e-05	0.000408	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—hematologic cancer	9.27e-05	0.000407	CcSEcCtD
Carbinoxamine—Asthenia—Gemcitabine—hematologic cancer	9.24e-05	0.000406	CcSEcCtD
Carbinoxamine—Dizziness—Ifosfamide—hematologic cancer	9.21e-05	0.000404	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—hematologic cancer	9.16e-05	0.000402	CcSEcCtD
Carbinoxamine—Vision blurred—Prednisone—hematologic cancer	9.1e-05	0.0004	CcSEcCtD
Carbinoxamine—Nausea—Thiotepa—hematologic cancer	9.1e-05	0.000399	CcSEcCtD
Carbinoxamine—Feeling abnormal—Etoposide—hematologic cancer	9.07e-05	0.000398	CcSEcCtD
Carbinoxamine—Diarrhoea—Mitoxantrone—hematologic cancer	9.05e-05	0.000397	CcSEcCtD
Carbinoxamine—Diarrhoea—Irinotecan—hematologic cancer	9.05e-05	0.000397	CcSEcCtD
Carbinoxamine—Vomiting—Carmustine—hematologic cancer	9.05e-05	0.000397	CcSEcCtD
Carbinoxamine—Insomnia—Triamcinolone—hematologic cancer	9.02e-05	0.000396	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—hematologic cancer	9.02e-05	0.000396	CcSEcCtD
Carbinoxamine—Dizziness—Vincristine—hematologic cancer	8.98e-05	0.000394	CcSEcCtD
Carbinoxamine—Vomiting—Alitretinoin—hematologic cancer	8.96e-05	0.000394	CcSEcCtD
Carbinoxamine—Paraesthesia—Triamcinolone—hematologic cancer	8.96e-05	0.000393	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—hematologic cancer	8.95e-05	0.000393	CcSEcCtD
Carbinoxamine—Feeling abnormal—Prednisolone—hematologic cancer	8.94e-05	0.000393	CcSEcCtD
Carbinoxamine—Headache—Carmustine—hematologic cancer	8.91e-05	0.000391	CcSEcCtD
Carbinoxamine—Agitation—Prednisone—hematologic cancer	8.88e-05	0.00039	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Betamethasone—hematologic cancer	8.86e-05	0.000389	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dexamethasone—hematologic cancer	8.86e-05	0.000389	CcSEcCtD
Carbinoxamine—Vomiting—Ifosfamide—hematologic cancer	8.86e-05	0.000389	CcSEcCtD
Carbinoxamine—CYP2B6—blood—hematologic cancer	8.84e-05	0.0373	CbGeAlD
Carbinoxamine—Chlorpromazine—SLC22A1—hematologic cancer	8.84e-05	0.13	CrCbGaD
Carbinoxamine—Tachycardia—Betamethasone—hematologic cancer	8.84e-05	0.000388	CcSEcCtD
Carbinoxamine—Tachycardia—Dexamethasone—hematologic cancer	8.84e-05	0.000388	CcSEcCtD
Carbinoxamine—Headache—Alitretinoin—hematologic cancer	8.83e-05	0.000388	CcSEcCtD
Carbinoxamine—Diarrhoea—Gemcitabine—hematologic cancer	8.81e-05	0.000387	CcSEcCtD
Carbinoxamine—Nausea—Thalidomide—hematologic cancer	8.8e-05	0.000386	CcSEcCtD
Carbinoxamine—Dyspepsia—Triamcinolone—hematologic cancer	8.78e-05	0.000386	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—hematologic cancer	8.77e-05	0.000385	CcSEcCtD
Carbinoxamine—CYP2C9—blood—hematologic cancer	8.75e-05	0.0369	CbGeAlD
Carbinoxamine—Hyperhidrosis—Betamethasone—hematologic cancer	8.75e-05	0.000384	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Dexamethasone—hematologic cancer	8.75e-05	0.000384	CcSEcCtD
Carbinoxamine—Dizziness—Irinotecan—hematologic cancer	8.75e-05	0.000384	CcSEcCtD
Carbinoxamine—Urticaria—Etoposide—hematologic cancer	8.74e-05	0.000384	CcSEcCtD
Carbinoxamine—Vertigo—Prednisone—hematologic cancer	8.68e-05	0.000381	CcSEcCtD
Carbinoxamine—Tinnitus—Methotrexate—hematologic cancer	8.65e-05	0.00038	CcSEcCtD
Carbinoxamine—Vomiting—Vincristine—hematologic cancer	8.63e-05	0.000379	CcSEcCtD
Carbinoxamine—Anorexia—Dexamethasone—hematologic cancer	8.63e-05	0.000379	CcSEcCtD
Carbinoxamine—Anorexia—Betamethasone—hematologic cancer	8.63e-05	0.000379	CcSEcCtD
Carbinoxamine—Urticaria—Prednisolone—hematologic cancer	8.62e-05	0.000379	CcSEcCtD
Carbinoxamine—Asthenia—Cisplatin—hematologic cancer	8.62e-05	0.000378	CcSEcCtD
Carbinoxamine—Fatigue—Triamcinolone—hematologic cancer	8.6e-05	0.000378	CcSEcCtD
Carbinoxamine—Headache—Vincristine—hematologic cancer	8.51e-05	0.000374	CcSEcCtD
Carbinoxamine—Hypotension—Dexamethasone—hematologic cancer	8.46e-05	0.000372	CcSEcCtD
Carbinoxamine—Hypotension—Betamethasone—hematologic cancer	8.46e-05	0.000372	CcSEcCtD
Carbinoxamine—Nausea—Carmustine—hematologic cancer	8.45e-05	0.000371	CcSEcCtD
Carbinoxamine—Vomiting—Mitoxantrone—hematologic cancer	8.41e-05	0.000369	CcSEcCtD
Carbinoxamine—Vomiting—Irinotecan—hematologic cancer	8.41e-05	0.000369	CcSEcCtD
Carbinoxamine—Nausea—Alitretinoin—hematologic cancer	8.37e-05	0.000368	CcSEcCtD
Carbinoxamine—Convulsion—Prednisone—hematologic cancer	8.37e-05	0.000368	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—hematologic cancer	8.35e-05	0.000367	CcSEcCtD
Carbinoxamine—Chills—Methotrexate—hematologic cancer	8.32e-05	0.000365	CcSEcCtD
Carbinoxamine—CYP2E1—blood—hematologic cancer	8.29e-05	0.035	CbGeAlD
Carbinoxamine—Headache—Irinotecan—hematologic cancer	8.29e-05	0.000364	CcSEcCtD
Carbinoxamine—Headache—Mitoxantrone—hematologic cancer	8.29e-05	0.000364	CcSEcCtD
Carbinoxamine—Nausea—Ifosfamide—hematologic cancer	8.27e-05	0.000363	CcSEcCtD
Carbinoxamine—Feeling abnormal—Triamcinolone—hematologic cancer	8.22e-05	0.000361	CcSEcCtD
Carbinoxamine—Diarrhoea—Cisplatin—hematologic cancer	8.22e-05	0.000361	CcSEcCtD
Carbinoxamine—Vomiting—Gemcitabine—hematologic cancer	8.19e-05	0.00036	CcSEcCtD
Carbinoxamine—Insomnia—Betamethasone—hematologic cancer	8.19e-05	0.00036	CcSEcCtD
Carbinoxamine—Insomnia—Dexamethasone—hematologic cancer	8.19e-05	0.00036	CcSEcCtD
Carbinoxamine—CYP2C8—testis—hematologic cancer	8.15e-05	0.0344	CbGeAlD
Carbinoxamine—Paraesthesia—Dexamethasone—hematologic cancer	8.13e-05	0.000357	CcSEcCtD
Carbinoxamine—Paraesthesia—Betamethasone—hematologic cancer	8.13e-05	0.000357	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—hematologic cancer	8.09e-05	0.000355	CcSEcCtD
Carbinoxamine—Headache—Gemcitabine—hematologic cancer	8.07e-05	0.000354	CcSEcCtD
Carbinoxamine—Nausea—Vincristine—hematologic cancer	8.07e-05	0.000354	CcSEcCtD
Carbinoxamine—Dyspepsia—Dexamethasone—hematologic cancer	7.97e-05	0.00035	CcSEcCtD
Carbinoxamine—Dyspepsia—Betamethasone—hematologic cancer	7.97e-05	0.00035	CcSEcCtD
Carbinoxamine—Urticaria—Triamcinolone—hematologic cancer	7.93e-05	0.000348	CcSEcCtD
Carbinoxamine—Asthenia—Etoposide—hematologic cancer	7.89e-05	0.000347	CcSEcCtD
Carbinoxamine—Decreased appetite—Dexamethasone—hematologic cancer	7.87e-05	0.000346	CcSEcCtD
Carbinoxamine—Decreased appetite—Betamethasone—hematologic cancer	7.87e-05	0.000346	CcSEcCtD
Carbinoxamine—Nausea—Mitoxantrone—hematologic cancer	7.86e-05	0.000345	CcSEcCtD
Carbinoxamine—Nausea—Irinotecan—hematologic cancer	7.86e-05	0.000345	CcSEcCtD
Carbinoxamine—Fatigue—Dexamethasone—hematologic cancer	7.81e-05	0.000343	CcSEcCtD
Carbinoxamine—Fatigue—Betamethasone—hematologic cancer	7.81e-05	0.000343	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—hematologic cancer	7.79e-05	0.000342	CcSEcCtD
Carbinoxamine—CYP2B6—lung—hematologic cancer	7.75e-05	0.0327	CbGeAlD
Carbinoxamine—Tachycardia—Prednisone—hematologic cancer	7.7e-05	0.000338	CcSEcCtD
Carbinoxamine—Nausea—Gemcitabine—hematologic cancer	7.65e-05	0.000336	CcSEcCtD
Carbinoxamine—Vomiting—Cisplatin—hematologic cancer	7.64e-05	0.000335	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Prednisone—hematologic cancer	7.62e-05	0.000335	CcSEcCtD
Carbinoxamine—Vision blurred—Methotrexate—hematologic cancer	7.61e-05	0.000334	CcSEcCtD
Carbinoxamine—HRH1—lung—hematologic cancer	7.57e-05	0.0319	CbGeAlD
Carbinoxamine—Diarrhoea—Etoposide—hematologic cancer	7.53e-05	0.000331	CcSEcCtD
Carbinoxamine—Anorexia—Prednisone—hematologic cancer	7.52e-05	0.00033	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—hematologic cancer	7.49e-05	0.000329	CcSEcCtD
Carbinoxamine—Feeling abnormal—Betamethasone—hematologic cancer	7.46e-05	0.000328	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dexamethasone—hematologic cancer	7.46e-05	0.000328	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—hematologic cancer	7.41e-05	0.000326	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—hematologic cancer	7.34e-05	0.000322	CcSEcCtD
Carbinoxamine—CYP2B6—testis—hematologic cancer	7.31e-05	0.0308	CbGeAlD
Carbinoxamine—Dizziness—Etoposide—hematologic cancer	7.27e-05	0.000319	CcSEcCtD
Carbinoxamine—CYP2E1—lung—hematologic cancer	7.27e-05	0.0307	CbGeAlD
Carbinoxamine—Vertigo—Methotrexate—hematologic cancer	7.25e-05	0.000319	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—hematologic cancer	7.21e-05	0.000316	CcSEcCtD
Carbinoxamine—Urticaria—Dexamethasone—hematologic cancer	7.19e-05	0.000316	CcSEcCtD
Carbinoxamine—Urticaria—Betamethasone—hematologic cancer	7.19e-05	0.000316	CcSEcCtD
Carbinoxamine—Dizziness—Prednisolone—hematologic cancer	7.18e-05	0.000315	CcSEcCtD
Carbinoxamine—Asthenia—Triamcinolone—hematologic cancer	7.16e-05	0.000314	CcSEcCtD
Carbinoxamine—HRH1—testis—hematologic cancer	7.14e-05	0.0301	CbGeAlD
Carbinoxamine—Nausea—Cisplatin—hematologic cancer	7.13e-05	0.000313	CcSEcCtD
Carbinoxamine—Insomnia—Prednisone—hematologic cancer	7.13e-05	0.000313	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—hematologic cancer	7.12e-05	0.000313	CcSEcCtD
Carbinoxamine—Paraesthesia—Prednisone—hematologic cancer	7.08e-05	0.000311	CcSEcCtD
Carbinoxamine—Convulsion—Methotrexate—hematologic cancer	7e-05	0.000307	CcSEcCtD
Carbinoxamine—Vomiting—Etoposide—hematologic cancer	6.99e-05	0.000307	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—hematologic cancer	6.94e-05	0.000305	CcSEcCtD
Carbinoxamine—Dyspepsia—Prednisone—hematologic cancer	6.94e-05	0.000305	CcSEcCtD
Carbinoxamine—Headache—Etoposide—hematologic cancer	6.89e-05	0.000303	CcSEcCtD
Carbinoxamine—CYP2E1—testis—hematologic cancer	6.86e-05	0.0289	CbGeAlD
Carbinoxamine—Tension—Doxorubicin—hematologic cancer	6.86e-05	0.000301	CcSEcCtD
Carbinoxamine—Decreased appetite—Prednisone—hematologic cancer	6.85e-05	0.000301	CcSEcCtD
Carbinoxamine—Fatigue—Prednisone—hematologic cancer	6.8e-05	0.000299	CcSEcCtD
Carbinoxamine—Headache—Prednisolone—hematologic cancer	6.8e-05	0.000299	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—hematologic cancer	6.79e-05	0.000298	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—hematologic cancer	6.79e-05	0.000298	CcSEcCtD
Carbinoxamine—Constipation—Prednisone—hematologic cancer	6.74e-05	0.000296	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—hematologic cancer	6.68e-05	0.000293	CcSEcCtD
Carbinoxamine—CYP3A4—blood—hematologic cancer	6.67e-05	0.0282	CbGeAlD
Carbinoxamine—Confusional state—Methotrexate—hematologic cancer	6.64e-05	0.000292	CcSEcCtD
Carbinoxamine—Dizziness—Triamcinolone—hematologic cancer	6.6e-05	0.00029	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—hematologic cancer	6.59e-05	0.000289	CcSEcCtD
Carbinoxamine—CYP2D6—blood—hematologic cancer	6.57e-05	0.0277	CbGeAlD
Carbinoxamine—Convulsion—Epirubicin—hematologic cancer	6.55e-05	0.000287	CcSEcCtD
Carbinoxamine—Nausea—Etoposide—hematologic cancer	6.53e-05	0.000287	CcSEcCtD
Carbinoxamine—Feeling abnormal—Prednisone—hematologic cancer	6.5e-05	0.000285	CcSEcCtD
Carbinoxamine—Asthenia—Betamethasone—hematologic cancer	6.5e-05	0.000285	CcSEcCtD
Carbinoxamine—Asthenia—Dexamethasone—hematologic cancer	6.5e-05	0.000285	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Methotrexate—hematologic cancer	6.45e-05	0.000283	CcSEcCtD
Carbinoxamine—Nausea—Prednisolone—hematologic cancer	6.45e-05	0.000283	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—hematologic cancer	6.42e-05	0.000282	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Methotrexate—hematologic cancer	6.37e-05	0.00028	CcSEcCtD
Carbinoxamine—Vomiting—Triamcinolone—hematologic cancer	6.34e-05	0.000279	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—hematologic cancer	6.28e-05	0.000276	CcSEcCtD
Carbinoxamine—Anorexia—Methotrexate—hematologic cancer	6.28e-05	0.000276	CcSEcCtD
Carbinoxamine—Urticaria—Prednisone—hematologic cancer	6.26e-05	0.000275	CcSEcCtD
Carbinoxamine—Headache—Triamcinolone—hematologic cancer	6.25e-05	0.000275	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—hematologic cancer	6.22e-05	0.000273	CcSEcCtD
Carbinoxamine—Diarrhoea—Dexamethasone—hematologic cancer	6.19e-05	0.000272	CcSEcCtD
Carbinoxamine—Diarrhoea—Betamethasone—hematologic cancer	6.19e-05	0.000272	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—hematologic cancer	6.18e-05	0.000271	CcSEcCtD
Carbinoxamine—Hypotension—Methotrexate—hematologic cancer	6.16e-05	0.00027	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—hematologic cancer	6.06e-05	0.000266	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—hematologic cancer	6.04e-05	0.000265	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—hematologic cancer	6.02e-05	0.000264	CcSEcCtD
Carbinoxamine—Dizziness—Betamethasone—hematologic cancer	5.99e-05	0.000263	CcSEcCtD
Carbinoxamine—Dizziness—Dexamethasone—hematologic cancer	5.99e-05	0.000263	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—hematologic cancer	5.96e-05	0.000262	CcSEcCtD
Carbinoxamine—Insomnia—Methotrexate—hematologic cancer	5.96e-05	0.000262	CcSEcCtD
Carbinoxamine—Nausea—Triamcinolone—hematologic cancer	5.93e-05	0.00026	CcSEcCtD
Carbinoxamine—Paraesthesia—Methotrexate—hematologic cancer	5.92e-05	0.00026	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—hematologic cancer	5.88e-05	0.000258	CcSEcCtD
Carbinoxamine—Somnolence—Methotrexate—hematologic cancer	5.86e-05	0.000257	CcSEcCtD
Carbinoxamine—Dyspepsia—Methotrexate—hematologic cancer	5.8e-05	0.000255	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—hematologic cancer	5.76e-05	0.000253	CcSEcCtD
Carbinoxamine—Vomiting—Dexamethasone—hematologic cancer	5.76e-05	0.000253	CcSEcCtD
Carbinoxamine—Vomiting—Betamethasone—hematologic cancer	5.76e-05	0.000253	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—hematologic cancer	5.75e-05	0.000253	CcSEcCtD
Carbinoxamine—Decreased appetite—Methotrexate—hematologic cancer	5.73e-05	0.000252	CcSEcCtD
Carbinoxamine—Fatigue—Methotrexate—hematologic cancer	5.68e-05	0.000249	CcSEcCtD
Carbinoxamine—Headache—Betamethasone—hematologic cancer	5.67e-05	0.000249	CcSEcCtD
Carbinoxamine—Headache—Dexamethasone—hematologic cancer	5.67e-05	0.000249	CcSEcCtD
Carbinoxamine—Asthenia—Prednisone—hematologic cancer	5.66e-05	0.000248	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—hematologic cancer	5.59e-05	0.000245	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—hematologic cancer	5.58e-05	0.000245	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—hematologic cancer	5.57e-05	0.000245	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—hematologic cancer	5.54e-05	0.000243	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—hematologic cancer	5.52e-05	0.000242	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—hematologic cancer	5.48e-05	0.000241	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—hematologic cancer	5.44e-05	0.000239	CcSEcCtD
Carbinoxamine—CYP2D6—testis—hematologic cancer	5.43e-05	0.0229	CbGeAlD
Carbinoxamine—Feeling abnormal—Methotrexate—hematologic cancer	5.43e-05	0.000238	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—hematologic cancer	5.43e-05	0.000238	CcSEcCtD
Carbinoxamine—Diarrhoea—Prednisone—hematologic cancer	5.39e-05	0.000237	CcSEcCtD
Carbinoxamine—Nausea—Betamethasone—hematologic cancer	5.38e-05	0.000236	CcSEcCtD
Carbinoxamine—Nausea—Dexamethasone—hematologic cancer	5.38e-05	0.000236	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—hematologic cancer	5.36e-05	0.000235	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—hematologic cancer	5.33e-05	0.000234	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—hematologic cancer	5.32e-05	0.000233	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—hematologic cancer	5.27e-05	0.000232	CcSEcCtD
Carbinoxamine—Urticaria—Methotrexate—hematologic cancer	5.23e-05	0.00023	CcSEcCtD
Carbinoxamine—Dizziness—Prednisone—hematologic cancer	5.21e-05	0.000229	CcSEcCtD
Carbinoxamine—HRH1—lymph node—hematologic cancer	5.18e-05	0.0218	CbGeAlD
Carbinoxamine—Insomnia—Doxorubicin—hematologic cancer	5.16e-05	0.000227	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—hematologic cancer	5.12e-05	0.000225	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—hematologic cancer	5.08e-05	0.000223	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—hematologic cancer	5.07e-05	0.000223	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—hematologic cancer	5.02e-05	0.000221	CcSEcCtD
Carbinoxamine—Vomiting—Prednisone—hematologic cancer	5.01e-05	0.00022	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—hematologic cancer	4.96e-05	0.000218	CcSEcCtD
Carbinoxamine—Headache—Prednisone—hematologic cancer	4.94e-05	0.000217	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—hematologic cancer	4.92e-05	0.000216	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—hematologic cancer	4.9e-05	0.000215	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—hematologic cancer	4.88e-05	0.000214	CcSEcCtD
Carbinoxamine—Asthenia—Methotrexate—hematologic cancer	4.73e-05	0.000208	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—hematologic cancer	4.7e-05	0.000206	CcSEcCtD
Carbinoxamine—Nausea—Prednisone—hematologic cancer	4.68e-05	0.000206	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—hematologic cancer	4.53e-05	0.000199	CcSEcCtD
Carbinoxamine—Diarrhoea—Methotrexate—hematologic cancer	4.51e-05	0.000198	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—hematologic cancer	4.42e-05	0.000194	CcSEcCtD
Carbinoxamine—Dizziness—Methotrexate—hematologic cancer	4.36e-05	0.000191	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—hematologic cancer	4.22e-05	0.000185	CcSEcCtD
Carbinoxamine—Vomiting—Methotrexate—hematologic cancer	4.19e-05	0.000184	CcSEcCtD
Carbinoxamine—Headache—Methotrexate—hematologic cancer	4.13e-05	0.000181	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—hematologic cancer	4.09e-05	0.00018	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—hematologic cancer	4.08e-05	0.000179	CcSEcCtD
Carbinoxamine—Clomipramine—ALB—hematologic cancer	3.93e-05	0.0576	CrCbGaD
Carbinoxamine—Vomiting—Epirubicin—hematologic cancer	3.92e-05	0.000172	CcSEcCtD
Carbinoxamine—Nausea—Methotrexate—hematologic cancer	3.91e-05	0.000172	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—hematologic cancer	3.9e-05	0.000171	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—hematologic cancer	3.86e-05	0.00017	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—hematologic cancer	3.77e-05	0.000166	CcSEcCtD
Carbinoxamine—Clomipramine—ABCB1—hematologic cancer	3.75e-05	0.0549	CrCbGaD
Carbinoxamine—Chlorprothixene—ABCB1—hematologic cancer	3.73e-05	0.0547	CrCbGaD
Carbinoxamine—Nausea—Epirubicin—hematologic cancer	3.66e-05	0.000161	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—hematologic cancer	3.63e-05	0.000159	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—hematologic cancer	3.57e-05	0.000157	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—hematologic cancer	3.39e-05	0.000149	CcSEcCtD
Carbinoxamine—Chlorpromazine—ALB—hematologic cancer	2.69e-05	0.0395	CrCbGaD
Carbinoxamine—Chlorpromazine—ABCB1—hematologic cancer	2.57e-05	0.0377	CrCbGaD
Carbinoxamine—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.42e-06	0.000191	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.41e-06	0.000191	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	4.41e-06	0.000191	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GRB2—hematologic cancer	4.38e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.38e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.38e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.38e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.38e-06	0.00019	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	4.38e-06	0.000189	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	4.37e-06	0.000189	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SDC1—hematologic cancer	4.32e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTP1—hematologic cancer	4.32e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.31e-06	0.000187	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KITLG—hematologic cancer	4.31e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SDC1—hematologic cancer	4.28e-06	0.000185	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.24e-06	0.000183	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYCS—hematologic cancer	4.23e-06	0.000183	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	4.21e-06	0.000182	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.21e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.2e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	4.18e-06	0.000181	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.17e-06	0.000181	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	4.13e-06	0.000179	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.12e-06	0.000178	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.09e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCB1—hematologic cancer	4.09e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.05e-06	0.000175	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.05e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CD86—hematologic cancer	4.04e-06	0.000175	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.04e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	4.02e-06	0.000174	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CA9—hematologic cancer	4.01e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.01e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.99e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD44—hematologic cancer	3.99e-06	0.000173	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HES1—hematologic cancer	3.98e-06	0.000172	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.97e-06	0.000172	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.97e-06	0.000172	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	3.96e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.96e-06	0.000171	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF1—hematologic cancer	3.92e-06	0.00017	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CSF2—hematologic cancer	3.92e-06	0.00017	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.91e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.86e-06	0.000167	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	3.86e-06	0.000167	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	3.86e-06	0.000167	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	3.85e-06	0.000167	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	3.82e-06	0.000165	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	3.79e-06	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.78e-06	0.000164	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	3.78e-06	0.000164	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JAK1—hematologic cancer	3.78e-06	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.78e-06	0.000164	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.77e-06	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.75e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.73e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TXN—hematologic cancer	3.73e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.73e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.73e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD44—hematologic cancer	3.67e-06	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.67e-06	0.000159	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.65e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD44—hematologic cancer	3.64e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.64e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.61e-06	0.000156	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.58e-06	0.000155	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.56e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.53e-06	0.000153	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	3.53e-06	0.000153	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.51e-06	0.000152	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL2—hematologic cancer	3.5e-06	0.000152	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.5e-06	0.000152	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TERT—hematologic cancer	3.49e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.47e-06	0.00015	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.45e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYCS—hematologic cancer	3.44e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.43e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.43e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.42e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.41e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.41e-06	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	3.41e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.38e-06	0.000146	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TSC2—hematologic cancer	3.33e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.33e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.32e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.22e-06	0.000139	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.22e-06	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	3.2e-06	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	3.17e-06	0.000137	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.15e-06	0.000136	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.12e-06	0.000135	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.12e-06	0.000135	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—hematologic cancer	3.11e-06	0.000135	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.1e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.08e-06	0.000133	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FN1—hematologic cancer	3.07e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.06e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.06e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.06e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.04e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTR—hematologic cancer	3.04e-06	0.000131	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	3.04e-06	0.000131	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BAD—hematologic cancer	3.04e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.04e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.03e-06	0.000131	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	3.01e-06	0.00013	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.01e-06	0.00013	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.98e-06	0.000129	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CD80—hematologic cancer	2.95e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.95e-06	0.000127	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	2.94e-06	0.000127	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KIT—hematologic cancer	2.94e-06	0.000127	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	2.94e-06	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.94e-06	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.9e-06	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	2.89e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.89e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.87e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.82e-06	0.000122	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	2.82e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.81e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.81e-06	0.000122	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CREB1—hematologic cancer	2.8e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.79e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.79e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.79e-06	0.000121	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BRAF—hematologic cancer	2.76e-06	0.00012	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—hematologic cancer	2.74e-06	0.000119	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6R—hematologic cancer	2.73e-06	0.000118	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.73e-06	0.000118	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	2.73e-06	0.000118	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.7e-06	0.000117	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.67e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.64e-06	0.000114	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—hematologic cancer	2.61e-06	0.000113	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	2.6e-06	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.59e-06	0.000112	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	2.59e-06	0.000112	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.56e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—hematologic cancer	2.56e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.55e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	2.53e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.5e-06	0.000108	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.49e-06	0.000108	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF2—hematologic cancer	2.48e-06	0.000107	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.47e-06	0.000107	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.44e-06	0.000106	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	2.44e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD44—hematologic cancer	2.4e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.4e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.38e-06	0.000103	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JAK2—hematologic cancer	2.37e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.36e-06	0.000102	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	2.33e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MDM2—hematologic cancer	2.32e-06	0.0001	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.3e-06	9.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.27e-06	9.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.27e-06	9.83e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.26e-06	9.77e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.26e-06	9.77e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MTOR—hematologic cancer	2.25e-06	9.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	2.25e-06	9.76e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.24e-06	9.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—hematologic cancer	2.21e-06	9.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.17e-06	9.41e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	2.15e-06	9.31e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	2.12e-06	9.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.11e-06	9.15e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.11e-06	9.12e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.09e-06	9.06e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.09e-06	9.05e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.07e-06	8.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.07e-06	8.97e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2—hematologic cancer	2.07e-06	8.96e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.06e-06	8.92e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.02e-06	8.73e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUN—hematologic cancer	2.01e-06	8.72e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2e-06	8.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2e-06	8.65e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.99e-06	8.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—hematologic cancer	1.97e-06	8.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.95e-06	8.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.95e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.95e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.95e-06	8.43e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.94e-06	8.39e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.92e-06	8.32e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.91e-06	8.25e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.9e-06	8.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—EP300—hematologic cancer	1.9e-06	8.22e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.9e-06	8.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.89e-06	8.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—EP300—hematologic cancer	1.86e-06	8.05e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.86e-06	8.04e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.84e-06	7.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.84e-06	7.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.84e-06	7.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.82e-06	7.88e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—hematologic cancer	1.81e-06	7.85e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.81e-06	7.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—hematologic cancer	1.8e-06	7.78e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.76e-06	7.61e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.74e-06	7.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.74e-06	7.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.74e-06	7.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.73e-06	7.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.72e-06	7.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.69e-06	7.3e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.66e-06	7.2e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.63e-06	7.04e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.62e-06	7.01e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.61e-06	6.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—EP300—hematologic cancer	1.61e-06	6.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.6e-06	6.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.59e-06	6.87e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.5e-06	6.51e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.5e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—EP300—hematologic cancer	1.43e-06	6.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.4e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.38e-06	5.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.38e-06	5.96e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.37e-06	5.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.37e-06	5.94e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.37e-06	5.91e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.33e-06	5.75e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—EP300—hematologic cancer	1.32e-06	5.71e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—EP300—hematologic cancer	1.31e-06	5.66e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.27e-06	5.5e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.27e-06	5.48e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.22e-06	5.27e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.2e-06	5.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.19e-06	5.15e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—hematologic cancer	1.19e-06	5.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.15e-06	4.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.13e-06	4.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.12e-06	4.86e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.12e-06	4.86e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.06e-06	4.59e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.05e-06	4.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.76e-07	4.23e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—hematologic cancer	9.71e-07	4.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.68e-07	4.19e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTEN—hematologic cancer	9.05e-07	3.92e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—hematologic cancer	8.67e-07	3.75e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—EP300—hematologic cancer	8.63e-07	3.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—hematologic cancer	7.98e-07	3.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.91e-07	3.42e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.38e-07	2.76e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.21e-07	2.26e-05	CbGpPWpGaD
